Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules

摘要

BackgroundThe long-term antibody response to measles vaccine (MV) administered at age 6 months with or without subsequent doses is not well documented.